Physician

Keith Alan Lopatka, M.D.

According to 2025 Medicare claims, Keith Lopatka, M.D. (NPI: 1770509648) practices micrographic dermatologic surgery in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ILLINOIS DERMATOLOGY INSTITUTE, LLC (NPI: 1891920898; TIN: 26-3341995) and primary practice location at 60463-1196.

Lopatka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,041 traditional Medicare patients, billed 6,912 HCPCS/CPT codes, and received $803,010 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,234 prescription claims across 526 beneficiaries totaling $648,265 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 304 records totaling $7,314. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $308,354 to $803,010. Similarly, Part D prescription costs have moved sharply higher in recent years, from $95,478 to $648,265. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	947	5,437	$308,354
2016	1,054	5,733	$390,675
2017	988	5,032	$290,811
2018	1,048	5,075	$317,739
2019	1,115	4,845	$337,350
2020	1,041	3,974	$354,133
2021	1,000	4,282	$444,501
2022	1,015	4,625	$495,756
2023	979	4,516	$508,176
2024	1,041	6,912	$803,010

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	234	492	$95,478
2016	297	620	$114,853
2017	352	781	$216,508
2018	350	734	$264,874
2019	426	910	$398,473
2020	461	1,085	$334,768
2021	476	1,021	$250,138
2022	471	952	$323,979
2023	415	1,010	$571,633
2024	526	1,234	$648,265

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	180	215	$309
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	588	817	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	332	456	$60
17000	Destruction of precancer skin growth, 1 growth	197	246	$41
17003	Destruction of precancer skin growth, 2-14 growths	158	696	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	12	784	$261,959
Dupixent Pen	Dupilumab	36	1,022	$147,210
Betamethasone Dipropionate	Betamethasone Dipropionate	188	4,350	$7,135
Tacrolimus	Tacrolimus	34	919	$4,166
Clobetasol Propionate	Clobetasol Propionate	51	1,373	$3,329

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	304	$7,314	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Keith Alan Lopatka, M.D.?

Tedicare shows public-source Medicare data for Keith Alan Lopatka, M.D. (NPI 1770509648), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keith Alan Lopatka, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Keith Alan Lopatka, M.D.?

Keith Alan Lopatka, M.D. is linked to ILLINOIS DERMATOLOGY INSTITUTE, LLC (billing NPI 1891920898) in the available physician profile data.

Does Keith Alan Lopatka, M.D. have Open Payments data?

Keith Alan Lopatka, M.D. has 304 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.